Position in CRMD
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$23,550
-$3,610 QoQ
Shares Held
3,000
-25.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#155
of 192 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Capital Management LLC holds $1,139,867 across 8 Biotechnology names. CRMD ranks #4 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,155 | $648,719 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
4,300 | $336,561 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
953 | $90,697 | |
| 4 | CRMD |
CorMedix Inc.
This page
|
3,000 | $23,550 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
300 | $16,362 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32 | $15,895 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
80 | $6,343 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
100 | $1,740 |
All Filings in CRMD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,550 | 3,000 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $27,160 | 4,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $58,150 | 5,000 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $69,780 | 6,000 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||